BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29694920)

  • 21. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models.
    Naito M; Matsuba Y; Sato S; Hirata H; Tsuruo T
    Clin Cancer Res; 2002 Feb; 8(2):582-8. PubMed ID: 11839680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversing P-Glycoprotein-Associated Multidrug Resistance of Breast Cancer by Targeted Acid-Cleavable Polysaccharide Nanoparticles with Lapatinib Sensitization.
    Sui J; He M; Yang Y; Ma M; Guo Z; Zhao M; Liang J; Sun Y; Fan Y; Zhang X
    ACS Appl Mater Interfaces; 2020 Nov; 12(46):51198-51211. PubMed ID: 33147005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells.
    Li PY; Lai PS; Hung WC; Syu WJ
    Biomacromolecules; 2010 Oct; 11(10):2576-82. PubMed ID: 20722436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
    Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
    Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
    Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
    Bidwell GL; Davis AN; Fokt I; Priebe W; Raucher D
    Invest New Drugs; 2007 Aug; 25(4):313-26. PubMed ID: 17483874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance.
    Zhao S; Tan S; Guo Y; Huang J; Chu M; Liu H; Zhang Z
    Biomacromolecules; 2013 Aug; 14(8):2636-46. PubMed ID: 23815156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.
    Chang X; Liu Z; Cao S; Bian J; Zheng D; Wang N; Guan Q; Wu Y; Zhang W; Li Z; Zuo D
    Toxicol Appl Pharmacol; 2022 Feb; 436():115883. PubMed ID: 35031325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A DM1-doped porous gold nanoshell system for NIR accelerated redox-responsive release and triple modal imaging guided photothermal synergistic chemotherapy.
    Xu P; Wang R; Yang W; Liu Y; He D; Ye Z; Chen D; Ding Y; Tu J; Shen Y
    J Nanobiotechnology; 2021 Mar; 19(1):77. PubMed ID: 33741008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells].
    Huang C; Cao P; Xie Z; Zhu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):317-22. PubMed ID: 21566283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.
    Wu J; Wang Q; Dong X; Xu M; Yang J; Yi X; Chen B; Dong X; Wang Y; Lou X; Xia F; Wang S; Dai J
    Theranostics; 2021; 11(8):3710-3724. PubMed ID: 33664857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG₂₀₀₀ micelles.
    Cai L; Qiu N; Xiang M; Tong R; Yan J; He L; Shi J; Chen T; Wen J; Wang W; Chen L
    Int J Nanomedicine; 2014; 9():243-55. PubMed ID: 24403830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activities of a 3'-azido analogue of Doxorubicin against drug-resistant cancer cells.
    Yu S; Zhang G; Zhang W; Luo H; Qiu L; Liu Q; Sun D; Wang PG; Wang F
    Int J Mol Sci; 2012; 13(3):3671-3684. PubMed ID: 22489175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P-glycoprotein expression level in non-small lung cancer.
    Wan J; Ling XA; Wang J; Ding GG; Wang X
    J Cell Mol Med; 2020 Nov; 24(21):12840-12847. PubMed ID: 32945069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles.
    Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H
    Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan, podophyllotoxin.
    Greenwald RB; Conover CD; Pendri A; Choe YH; Martinez A; Wu D; Guan S; Yao Z; Shum KL
    J Control Release; 1999 Sep; 61(3):281-94. PubMed ID: 10477801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L1EPO, a novel podophyllotoxin derivative overcomes P-glycoprotein-mediated multidrug resistance in K562/A02 cell line.
    Chen H; Wang J; Zhang J; Wang Y; Cao B; Bai S; Yu PF; Bi W; Xie W
    Biol Pharm Bull; 2009 Apr; 32(4):609-13. PubMed ID: 19336892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance.
    Zhang Y; Zeng X; Wang H; Fan R; Hu Y; Hu X; Li J
    Drug Deliv; 2021 Dec; 28(1):670-679. PubMed ID: 33792436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
    Dong X; Mattingly CA; Tseng MT; Cho MJ; Liu Y; Adams VR; Mumper RJ
    Cancer Res; 2009 May; 69(9):3918-26. PubMed ID: 19383919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer.
    Shi X; Yang X; Liu M; Wang R; Qiu N; Liu Y; Yang H; Ji J; Zhai G
    Carbohydr Polym; 2021 Feb; 254():117459. PubMed ID: 33357918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.